| Chypre | Turquie | Espagne | |
| Traitement de la maladie d'Alzheimer à l'aide de cellules souches | - | de $15,000 | de $20,000 |
Bookimed ne rajoute pas de frais pour les traitements de La maladie d'Alzheimer. Les tarifs proviennent des listes de prix officielles des cliniques. Vous payez directement à la clinique pour votre traitement à votre arrivée dans le pays.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans le traitement de La maladie d'Alzheimer et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de traitement de La maladie d'Alzheimer.
Cyprus follows European Union regulations for advanced Alzheimer's treatments like monoclonal antibodies. Legal authorization exists for drugs like lecanemab. However, practical availability in the public health system remains limited. Access requires confirmed amyloid pathology through specialized PET scans or lumbar punctures.
Bookimed Expert Insight: While German Medical Institute in Cyprus holds CHKS and ISO 45001:2018 certifications, advanced biological infusions are rare in local private clinics. Most regional specialists focus on diagnostic accuracy using nuclear medicine. Patients should verify if a clinic provides serial MRI monitoring before starting any infusion therapy.
Patient Consensus: Patients note that finding neurologists who coordinate evidence-based monitoring is more important than local drug availability. Many express caution regarding private clinics offering unproven infusion therapies or apheresis without clinical evidence.
Eligibility for breakthrough amyloid-targeting therapies in Cyprus requires a diagnosis of early-stage Alzheimer disease. Patients must show mild cognitive impairment or mild dementia. Diagnosis requires biomarker evidence from PET scans or spinal fluid analysis. Special authorization from Pharmaceutical Services is necessary for importation.
Bookimed Expert Insight: While German Medical Institute (GMI) holds CHKS and ISO 45001:2018 certifications, these advanced therapies are often handled through individual case evaluations. Patients should prepare cognitive records early. The clinic serves over 13,000 patients annually. This volume suggests high diagnostic capacity for complex neurological screenings.
Patient Consensus: Patients note that access is strictly referral-driven through the General Healthcare System (GESY). They emphasize bringing all previous testing records to the initial specialist consultation to avoid delays.
Patients can access specialized Alzheimer's care at the Cyprus Institute of Neurology and Genetics in Nicosia. The German Medical Institute in Limassol also offers neurological diagnostic pathways. These centers provide cognitive evaluations, genetic testing, and innovative neuromodulation therapies like Transcranial Pulse Stimulation.
Bookimed Expert Insight: Private hospitals like the German Medical Institute offer faster access to specialists for diagnostic reviews. This facility employs 90 doctors with training from Germany and the United Kingdom. Their multilingual team helps bridge communication gaps for international patients seeking second opinions on dementia. Coordination through these centers often reduces the month-long wait times seen at public institutes.
Patient Consensus: Patients note that private clinics in Limassol are much faster for scheduling initial specialist consultations. Many recommend starting with a formal diagnosis in Nicosia before arranging home nursing support locally.
Local associations in Cyprus provide non-pharmacological Alzheimer's care through psychosocial support, caregiver education, and resource navigation. These organizations offer peer-led groups, stress management workshops, and referrals to essential community services. They focus on reducing caregiver isolation and improving daily life for patients without relying on medication.
Bookimed Expert Insight: While German Medical Institute (GMI) serves 13,700 patients annually with ISO-certified quality, medical centers often focus on diagnostics. Real support for chronic care happens locally. Families should prioritize clinics with multilingual teams in Greek and English. This ensures seamless communication when coordinating with local NGOs or government departments for long-term respite care.
Patient Consensus: Families emphasize using local church networks and municipal helplines for practical help. Many find that confidential emotional support from organizations like the Samaritans is vital when they feel overwhelmed by daily caregiving tasks.
Standard medications and care for Alzheimer's are heavily covered by the Cypriot public healthcare system (GESY). The system uses a low-copayment model. Hospital stays and surgeries are completely free. Patients pay small fees for prescriptions and specialist visits. Beneficiaries must register with a personal doctor.
Bookimed Expert Insight: Cyprus provides high-quality infrastructure for complex cases at centers like German Medical Institute (GMI). While public coverage is broad, GMI treats over 13,000 patients annually using German-trained specialists. Patients seeking advanced diagnostics should ensure their personal doctor provides a GESY referral to maintain low costs.
Patient Consensus: Patients note that while standard visits and common medications are very affordable, newer branded drugs sometimes require private payment. It is important to confirm eligibility based on residence status before starting long-term Alzheimer's treatment.